Alliance Global Partners Initiates Coverage of UpHealth (UPH) with Buy Recommendation
Fintel reports that on June 9, 2023, Alliance Global Partners initiated coverage of UpHealth (NYSE:UPH) with a Buy recommendation.
Analyst Price Forecast Suggests 376.00% Upside
As of June 2, 2023, the average one-year price target for UpHealth is 7.14. The forecasts range from a low of 3.03 to a high of $11.55. The average price target represents an increase of 376.00% from its latest reported closing price of 1.50.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for UpHealth is 218MM, an increase of 32.26%. The projected annual non-GAAP EPS is -1.95.
What is the Fund Sentiment?
There are 52 funds or institutions reporting positions in UpHealth. This is a decrease of 4 owner(s) or 7.14% in the last quarter. Average portfolio weight of all funds dedicated to UPH is 0.00%, an increase of 22.09%. Total shares owned by institutions increased in the last three months by 64.46% to 4,241K shares. The put/call ratio of UPH is 0.01, indicating a bullish outlook.